Verified email-pattern data for Umecrine Cognition Ab is currently limited. You can still use the company insights and contact sections below.
Umecrine Cognition is developing a completely new type of drug for neurological disorders in the brain that can occur as a result of a number of underlying diseases and lead to severely reduced cognition and alertness.
The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy.
The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the mechanism of action is also relevant in a number of other indication areas.
The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy.
The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the mechanism of action is also relevant in a number of other indication areas.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Nanna Svartz Väg 6a (Floor 4), Karolinska Institutet Science Park,sweden
- Industry
- Biotechnology Research
- Website
- http://www.umecrinecognition.com
- Keywords
- pbc, biotech, cognitive disorders, drug development, neurological disorders, hepatic encephalopathy, primary biliary cholangitis, fatigue, golexanolone, cognitive function, parkinsons disease, GABAA receptor.
- HQ
- Solna, Stockholm County
Umecrine Cognition Ab Questions
Umecrine Cognition AB's website is http://www.umecrinecognition.com
Umecrine Cognition AB's LinkedIn profile is https://se.linkedin.com/company/umecrine-cognition-ab
Umecrine Cognition AB has
12 employees.
View email and phone details for 12
employees at Umecrine Cognition AB.
Umecrine Cognition AB's industry is
Biotechnology Research
Umecrine Cognition AB's top competitors are
Inify Laboratories,
Alba Health,
Xbrane Biopharma Ab,
H100,
Tirmed Pharma,
Spermosens Ab,
Aureal One,
Chosa Oncology,
Emp Metals Corp,
Cereno Scientific.
Umecrine Cognition AB's categories are Biotechnology Research
Umecrine Cognition AB's founding year is 2000
Explore related pages
Related company profiles:
Companies like Umecrine Cognition AB
Top Umecrine Cognition AB Employees
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.